Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
Abbott has previously opposed legislation to test strips, but noted an 89% increase in fentanyl deaths in Texas over the past year.
Read Full NewsSusan Corbridge, PhD, and Alanna Kavannagh, MSN, CCRN, discuss the role of advanced practice providers on the evolving pulmonary and critical care teams during CHEST 2025.
The phase 3 study aims to confirm findings from the HEALEY ALS platform trial in patients with early-stage rapidly progressive ALS, which suggested potential benefits of pridopidine across multiple domains.
Holzem spoke in this interview about several additional highlights from her session at SDPA Fall regarding red flags in dermatology and when to admit from the clinic.
Key Skin Cancer Terms Not Understood by Almost 1/3 of Patients Surveyed
1.
Second opinions don't significantly delay breast cancer treatment
2.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
3.
As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Oleanolic acid from grapes may increase chemotherapy effectiveness
1.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
2.
Cowden Syndrome and Cancer: Understanding the Risk Factors
3.
Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies
4.
Understanding QSOFA: A Vital Tool for Recognizing Sepsis
5.
Thyroid Cancer and Insulin Resistance: Unraveling the Complex Interplay for Better Patient Outcomes
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
2.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
3.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
4.
Navigating the Complexities of Ph Negative ALL - Part IV
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge